{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:44:20Z","timestamp":1792071860081,"version":"4.4.0"},"reference-count":28,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/ijmm.2015.2191","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T10:40:48Z","timestamp":1429612848000},"page":"139-149","source":"Crossref","is-referenced-by-count":43,"title":["Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia\/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant"],"prefix":"10.3892","volume":"36","author":[{"given":"NINGXIA","family":"SONG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEI","family":"GAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUIYING","family":"QIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHONGMEI","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUI","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HONG","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUQING","family":"LV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIANMIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"key20180107233020_b1-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.exphem.2008.03.004","article-title":"Isolation and characterization of CD146+ multipotent mesenchymal stromal cells","volume":"36","author":"Sorrentino","year":"2008","journal-title":"Exp Hematol"},{"key":"key20180107233020_b2-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"key":"key20180107233020_b3-ijmm-36-01-0139","first-page":"45","article-title":"Adult human mesenchymal stromal cells and the treatment of graft versus host disease","volume":"7","author":"Herrmann","year":"2014","journal-title":"Stem Cells Cloning"},{"key":"key20180107233020_b4-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"key20180107233020_b5-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-09-176198","article-title":"Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells","volume":"113","author":"Otsu","year":"2009","journal-title":"Blood"},{"key":"key20180107233020_b6-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J Exp Med"},{"key":"key20180107233020_b7-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/leu.2008.384","article-title":"Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1","volume":"23","author":"Zhu","year":"2009","journal-title":"Leukemia"},{"key":"key20180107233020_b8-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"e43408","DOI":"10.1371\/journal.pone.0043408","article-title":"HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4\/NF-kB pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"key20180107233020_b9-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/scd.2012.0165","article-title":"Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin\/\u03b2-catenin signaling pathway","volume":"22","author":"Menge","year":"2013","journal-title":"Stem Cells Dev"},{"key":"key20180107233020_b10-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/sj.onc.1210920","article-title":"Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice","volume":"27","author":"Gali\u00e8","year":"2008","journal-title":"Oncogene"},{"key":"key20180107233020_b11-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"key20180107233020_b12-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2008.06.011","article-title":"Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells","volume":"120","author":"Cirone","year":"2008","journal-title":"Immunol Lett"},{"key":"key20180107233020_b13-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cncr.27792","article-title":"Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"key20180107233020_b14-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0215(20010601)92:5<692::AID-IJC1237>3.0.CO;2-Z","article-title":"Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK\/T-celllymphoma: Implications for tumor immune escape mechanism","volume":"92","author":"Shen","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107233020_b15-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesen-chymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"key":"key20180107233020_b16-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jor.20925","article-title":"Use of fluorescence labeled mesenchymal stem cells in pluronic F127 and porous hydroxyapatite as a bone substitute for posterolateral spinal fusion","volume":"27","author":"Chen","year":"2009","journal-title":"J Orthop Res"},{"key":"key20180107233020_b17-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"key20180107233020_b18-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/pr.2011.56","article-title":"Role of mesenchymal stem cell therapy in Crohn\u2019s disease","volume":"71","author":"Dalal","year":"2012","journal-title":"Pediatr Res"},{"key":"key20180107233020_b19-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2012.12.009","article-title":"Mesenchymal stem cell transplantation in multiple sclerosis","volume":"333","author":"Cohen","year":"2013","journal-title":"J Neurol Sci"},{"key":"key20180107233020_b20-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/cbt.7.2.5296","article-title":"The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20180107233020_b21-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1096\/fj.13-244640","article-title":"Two sides of the same coin: Stem cells in cancer and regenerative medicine","volume":"28","author":"Ilmer","year":"2014","journal-title":"FASEB J"},{"key":"key20180107233020_b22-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.leu.2404489","article-title":"Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth","volume":"21","author":"Ramasamy","year":"2007","journal-title":"Leukemia"},{"key":"key20180107233020_b23-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.4049\/jimmunol.178.11.6840","article-title":"CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model","volume":"178","author":"Elpek","year":"2007","journal-title":"J Immunol"},{"key":"key20180107233020_b24-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2005.07.004","article-title":"Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo","volume":"80","author":"Zhu","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"key20180107233020_b25-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/01.tp.0000236098.13804.0b","article-title":"Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells","volume":"82","author":"Djouad","year":"2006","journal-title":"Transplantation"},{"key":"key20180107233020_b26-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2010.01.011","article-title":"Cotransplantation of mesenchymal stem cells might prevent death from graft-versus- host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning","volume":"16","author":"Baron","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20180107233020_b27-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"key20180107233020_b28-ijmm-36-01-0139","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotrans-plantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2015.2191\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:25Z","timestamp":1515369625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2015.2191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,4,21]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/ijmm.2015.2191"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2015.2191","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}